DPIIT recognised startup Government of India
Startup India
Esperer Bio-Research Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.57 Cr
▼ 32% YoY
Net loss · FY 2024
₹2.44 Cr
Net margin -154.8%
EBITDA · FY 2024
-₹1.99 Cr
EBITDA margin -126.4%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹4.4 Cr
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
12
Provident fund records
Directors on board
5
As per MCA filings
About Esperer Bio-Research Private Limited
Data last updated:
Esperer Bio-Research Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 16 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2018PTC312841. Its GSTIN is 27AAFCE1425P1ZF (Maharashtra).
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹4.4 Cr. It is led by directors including Venkataktyayani Sushmitha Gorantla and Sudipta Chattopadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 4Ba 4th Floor Gundecha Onclave Kherani Road Sakinaka Kurla W, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.57 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹2.44 Cr (net margin -154.8%) and EBITDA of -₹1.99 Cr (EBITDA margin -126.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Esperer.
Esperer Bio-Research Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0111272). For more details, the company can be reached via its website espererbioresearch.com.
Company details
CIN U24304MH2018PTC312841
Registration Number 312841
Incorporation Date 16 August 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0111272
Key People
Venkataktyayani Sushmitha Gorantla Director Sudipta Chattopadhyay Director Shubhankar Karmakar Director Recognitions & Rankings of Esperer Bio-Research
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0111272
Contact details
Esperer Bio-Research Private Limited's registered office is in Mumbai, Maharashtra. Its website is espererbioresearch.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 4Ba 4th Floor Gundecha Onclave Kherani Road Sakinaka Kurla W, Mumbai, Maharashtra, India – 400072
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Esperer Bio-Research Private Limited, buy the company report.
Comprehensive company report
Esperer Bio-Research Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Esperer Bio-Research operates one associated brand: ESPERER. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology drugs are manufactured by Esperer in Mumbai, India. | espererbioresearch.com |
Business activity
The main business activity of Esperer Bio-Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Esperer Bio-Research Private Limited, buy the company report.
Financials of Esperer Bio-Research Private Limited
FY 2025 filings availableEsperer Bio-Research Private Limited reported revenue of ₹1.57 Cr (down 32% YoY) for FY 2024.
Revenue · FY 2024
₹1.57 Cr ▼ 32%
Net loss · FY 2024
₹2.44 Cr margin -154.8%
EBITDA · FY 2024
-₹1.99 Cr margin -126.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 5%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 48%
3 years · compounded
▼ 20%
5 years · compounded
▼ 26%
Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.99 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -126.4% | ||||
| Net Profit Margin | -154.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Esperer Bio-Research Private Limited, buy the company report.
Board of directors of Esperer Bio-Research Private Limited
Esperer Bio-Research has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkataktyayani Sushmitha Gorantla | Director | 23 Feb 2021 | 5 Years 8 Months | Current |
| Sudipta Chattopadhyay Also directs: Health Voitho Technologies Private Limited, Esperer Onco Nutrition Private Limited, Solivara Enterprises Private Limited and 1 more | Director | 12 Mar 2020 | 6 Years 7 Months | Current |
| Shubhankar Karmakar | Director | 01 Jan 2020 | 6 Years 9 Months | Current |
| Sohilkumar Dahyabhai Tandel Also directs: Esperer Onco Nutrition Private Limited | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Raktim Chattopadhyay | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
Auditor
Esperer Bio-Research Private Limited is audited by Gorantla & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gorantla & Co | FY 2023 | 016943S |
Shareholding
The shareholding of Esperer Bio-Research Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Esperer Bio-Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Esperer Bio-Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Esperer Bio-Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Esperer Bio-Research Private Limited has a workforce of 12 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
-7.69%
GST
Esperer Bio-Research has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCE1425P1ZF | Maharashtra | Active | 04 Sep 2018 |
To see the full GST registrations and return filing status of Esperer Bio-Research Private Limited, buy the company report.
Recent activity
Esperer Bio-Research Private Limited has 10 board changes on record since 2018: 5 appointments and 5 cessations. The latest: Rajitha Yarrabathina ceased to be Director on 03 Jan 2024.
AGM
Esperer Bio-Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Esperer Bio-Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Rajitha Yarrabathina ceased to be Director.
Ceased
Venkataktyayani Sushmitha Gorantla ceased to be Additional Director.
Ceased
Shivshankar Gangaram Bangar ceased to be Director.
Appointed
Venkataktyayani Sushmitha Gorantla was appointed as Director.
Ceased
Shubhankar Karmakar ceased to be Additional Director.
Ceased
Raktim Chattopadhyay ceased to be Director.
Appointed
Sudipta Chattopadhyay was appointed as Director.
Appointed
Shubhankar Karmakar was appointed as Director.
Appointed
Raktim Chattopadhyay was appointed as Director.
Appointed
Sohilkumar Dahyabhai Tandel was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Esperer Bio-Research is an active private limited company based in Mumbai, Maharashtra, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 16 August 2018 (8+ years old) and is registered under CIN U24304MH2018PTC312841.
Esperer Bio-Research has 5 current directors:
- Venkataktyayani Sushmitha Gorantla - Director
- Sudipta Chattopadhyay - Director
- Shubhankar Karmakar - Director
- Sohilkumar Dahyabhai Tandel - Director
- Raktim Chattopadhyay - Director
The latest financial statements of Esperer Bio-Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Esperer Bio-Research is 27AAFCE1425P1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Esperer Bio-Research is U24304MH2018PTC312841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esperer Bio-Research was incorporated on 16 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Rajitha Yarrabathina ceased to be Director on 03 Jan 2024. Venkataktyayani Sushmitha Gorantla ceased to be Additional Director on 06 Jul 2021. Shivshankar Gangaram Bangar ceased to be Director on 12 Mar 2021. Esperer Bio-Research has 10 board changes on record in total.
Yes, Esperer Bio-Research is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Esperer Bio-Research is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0111272).
Esperer Bio-Research can be reached through the website espererbioresearch.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages